Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut-based ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

A federal bankruptcy court on November 18 formally approved Purdue’s $7.4 billion Chapter 11 plan to settle thousands of opioid-related lawsuits. The plan requires (1) a $6.5 billion contribution from ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

All 50 states agreed Monday to sign a settlement with Purdue Pharma, the company behind the highly addictive opioid Oxycontin, accepting $7.4 billion in payouts and prohibiting the Sackler family ...

Since Purdue Pharma filed for bankruptcy in 2019, Yoder's involvement in the proceedings has amounted to a de facto second job. Her responsibilities have included attending a number of court hearings, ...

The $7.5 billion opioid settlement involving Purdue Pharma took a major step forward Nov. 14 after the U.S. Bankruptcy Court for the Southern District of New York said it will confirm the company’s ...